In this study, we evaluated the mechanism(s) of KAI's reversal of cisplatin resistance via a FOXO3a-mediated signaling pathway in lung adenocarcinoma A549/DDP cells. The gene discussed is FOXO3; the disease is lung adenocarcinoma.